MENU
EDIT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Editas Medicine (EDIT) Ownership - Who owns Editas Medicine?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
265
Web
https://www.editasmedicine.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
228.66M
P/E Ratio
N/A
Total Cash
265.09M
Projected Growth
N/A
Total Debt
38.49M
Revenue
61.76M
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
3.21
Total Debt/Equity
N/A
Revenue/Share
0.75 USD as % of share price
Fundamentals
EDIT
Capitalization
229M
P/E Ratio
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash
265M
Total Cash/Share
3.21
Total Debt
38.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.75%
Revenue
61.8M
ROE
N/A
Book Value
176M
P/B Ratio
1.30
Cash Flow
N/A
Earnings
-2.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
3.75
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-222.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.61
Shares Held By Institutions
1.41B
Shares Outstanding - Current
82.5M
Total Liabilities
152M
Total Volume MTD
N/A
Value
1
Gain YTD
-70.780
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which translates genome editing technology into a novel class of human therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
11 Hurley Street
Phone
+1 617 401-9000
Employees
265
Web
https://www.editasmedicine.com